Michael Nall | CEO |
Tim Kennedy | CFO |
Bruce Voss | LHA IR |
Keay Nakae | Chardan Capital Markets |
Lauren Chung | WestPark Capital |
Ladies and gentlemen, thank you for standing by. Welcome to the Biocept Fourth Quarter and Full Year 2017 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared remarks, we will hold a question-and-answer session [Operator Instructions].
As a reminder, this conference call is being recorded today, March 28, 2018.